Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-27

Clinical Trial Update: A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topical danazol for pain associated with fibrocystic breast disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danazol (topical) (danazol)

Snippet

Sponsor: FemmePharma Global Healthcare, Inc. | Conditions: Fibrocystic Disease of Breast | Phase 2 | Status: COMPLETED